{"id":1388,"date":"2018-12-11T00:00:00","date_gmt":"2018-12-10T23:00:00","guid":{"rendered":"http:\/\/idlbiotech.com\/?p=1388"},"modified":"2021-05-26T10:09:39","modified_gmt":"2021-05-26T08:09:39","slug":"german-study-recommends-ubc-rapid-to-be-added-in-the-diagnostics-and-follow-up-of-high-risk-bladder-cancer","status":"publish","type":"post","link":"https:\/\/idldiagnostics.com\/se\/2018\/12\/11\/german-study-recommends-ubc-rapid-to-be-added-in-the-diagnostics-and-follow-up-of-high-risk-bladder-cancer\/","title":{"rendered":"Tysk studie rekommenderar UBC\u00ae Rapid att l\u00e4ggas till i diagnostik och uppf\u00f6ljning av h\u00f6grisk bl\u00e5scancer"},"content":{"rendered":"<p>International Journal of Molecular Sciences har publicerat en studie om UBC\u00ae Rapid. Totalt 530 urinprov inkluderades i multicenterstudien.<\/p>\n<p>F\u00f6rfattaren av studien drog slutsatsen att f\u00f6rh\u00f6jda v\u00e4rden av UBC<sup>\u00ae<\/sup>&nbsp;<span class=\"html-italic\">Snabb<\/span>&nbsp;Test i urin \u00e4r h\u00f6gre hos patienter med icke-muskelinvasiv bl\u00e5scancer av h\u00f6g grad j\u00e4mf\u00f6rt med tum\u00f6rer av l\u00e5g grad och den friska kontrollgruppen. K\u00e4nsligheten f\u00f6r icke-muskelinvasiva tum\u00f6rer av h\u00f6g grad \u00e4r mycket h\u00f6g med 75%vid en specificitet p\u00e5 93,8%. D\u00e4rf\u00f6r UBC<sup>\u00ae<\/sup>&nbsp;<span class=\"html-italic\">Snabb<\/span>&nbsp;Test har potential att vara en mer k\u00e4nslig och specifik urinproteinbiomark\u00f6r f\u00f6r att identifiera patienter med h\u00f6gradiga tum\u00f6rer som \u00e4r sv\u00e5ra att uppt\u00e4cka vid cystoskopi.<\/p>\n<p>Resultat f\u00f6r UBC<sup>\u00ae<\/sup>&nbsp;<span class=\"html-italic\">Snabb<\/span>Testerna i b\u00e5da studiecentra f\u00f6r den f\u00f6religgande multicenterstudien \u00e4r mycket lika och reproducerbara. UBC<sup>\u00ae<\/sup>&nbsp;<span class=\"html-italic\">Snabb<\/span>&nbsp;Testet \u00e4r standardiserat och kalibrerat, och d\u00e4rmed oberoende av anv\u00e4ndning, testbatch samt studieplats. UBC\u00ae Rapid Test b\u00f6r l\u00e4ggas till vid diagnostik och uppf\u00f6ljning f\u00f6r NMI-HG-tum\u00f6rer vid urinbl\u00e5secancer, \u00e4ven om cystoskopi fortfarande \u00e4r en viktig del av \u00f6vervakningen av urinbl\u00e5secancer.<\/p>","protected":false},"excerpt":{"rendered":"<p>International Journal of Molecular Sciences has published a study on UBC\u00ae Rapid. In total 530 urine samples was included in the multicenterstudy. The author of the study concluded that elevated values of UBC\u00ae&nbsp;Rapid&nbsp;Test in urine are higher in patients with non-muscle invasive high-grade bladder cancer in comparison to low-grade tumors and the healthy control group. [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":2510,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[37],"tags":[],"dipi_cpt_category":[],"class_list":["post-1388","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-bladder-cancer-health-information"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>German study recommends UBC\u00ae Rapid to be added in the diagnostics and follow-up of high risk bladder cancer - IDL Diagnostics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/idldiagnostics.com\/se\/2018\/12\/11\/german-study-recommends-ubc-rapid-to-be-added-in-the-diagnostics-and-follow-up-of-high-risk-bladder-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"German study recommends UBC\u00ae Rapid to be added in the diagnostics and follow-up of high risk bladder cancer - IDL Diagnostics\" \/>\n<meta property=\"og:description\" content=\"International Journal of Molecular Sciences has published a study on UBC\u00ae Rapid. In total 530 urine samples was included in the multicenterstudy. The author of the study concluded that elevated values of UBC\u00ae&nbsp;Rapid&nbsp;Test in urine are higher in patients with non-muscle invasive high-grade bladder cancer in comparison to low-grade tumors and the healthy control group. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/idldiagnostics.com\/se\/2018\/12\/11\/german-study-recommends-ubc-rapid-to-be-added-in-the-diagnostics-and-follow-up-of-high-risk-bladder-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"IDL Diagnostics\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/arocell\" \/>\n<meta property=\"article:published_time\" content=\"2018-12-10T23:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-05-26T08:09:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/IDL2281web.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1009\" \/>\n\t<meta property=\"og:image:height\" content=\"640\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"marie\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Skriven av\" \/>\n\t<meta name=\"twitter:data1\" content=\"marie\" \/>\n\t<meta name=\"twitter:label2\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2018\\\/12\\\/11\\\/german-study-recommends-ubc-rapid-to-be-added-in-the-diagnostics-and-follow-up-of-high-risk-bladder-cancer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2018\\\/12\\\/11\\\/german-study-recommends-ubc-rapid-to-be-added-in-the-diagnostics-and-follow-up-of-high-risk-bladder-cancer\\\/\"},\"author\":{\"name\":\"marie\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#\\\/schema\\\/person\\\/69060a052e2a36c16244e75262d43000\"},\"headline\":\"German study recommends UBC\u00ae Rapid to be added in the diagnostics and follow-up of high risk bladder cancer\",\"datePublished\":\"2018-12-10T23:00:00+00:00\",\"dateModified\":\"2021-05-26T08:09:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2018\\\/12\\\/11\\\/german-study-recommends-ubc-rapid-to-be-added-in-the-diagnostics-and-follow-up-of-high-risk-bladder-cancer\\\/\"},\"wordCount\":197,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2018\\\/12\\\/11\\\/german-study-recommends-ubc-rapid-to-be-added-in-the-diagnostics-and-follow-up-of-high-risk-bladder-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/IDL2281web.jpg\",\"articleSection\":[\"Bladder cancer\"],\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/idldiagnostics.com\\\/2018\\\/12\\\/11\\\/german-study-recommends-ubc-rapid-to-be-added-in-the-diagnostics-and-follow-up-of-high-risk-bladder-cancer\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2018\\\/12\\\/11\\\/german-study-recommends-ubc-rapid-to-be-added-in-the-diagnostics-and-follow-up-of-high-risk-bladder-cancer\\\/\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/2018\\\/12\\\/11\\\/german-study-recommends-ubc-rapid-to-be-added-in-the-diagnostics-and-follow-up-of-high-risk-bladder-cancer\\\/\",\"name\":\"German study recommends UBC\u00ae Rapid to be added in the diagnostics and follow-up of high risk bladder cancer - IDL Diagnostics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2018\\\/12\\\/11\\\/german-study-recommends-ubc-rapid-to-be-added-in-the-diagnostics-and-follow-up-of-high-risk-bladder-cancer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2018\\\/12\\\/11\\\/german-study-recommends-ubc-rapid-to-be-added-in-the-diagnostics-and-follow-up-of-high-risk-bladder-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/IDL2281web.jpg\",\"datePublished\":\"2018-12-10T23:00:00+00:00\",\"dateModified\":\"2021-05-26T08:09:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2018\\\/12\\\/11\\\/german-study-recommends-ubc-rapid-to-be-added-in-the-diagnostics-and-follow-up-of-high-risk-bladder-cancer\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/idldiagnostics.com\\\/2018\\\/12\\\/11\\\/german-study-recommends-ubc-rapid-to-be-added-in-the-diagnostics-and-follow-up-of-high-risk-bladder-cancer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2018\\\/12\\\/11\\\/german-study-recommends-ubc-rapid-to-be-added-in-the-diagnostics-and-follow-up-of-high-risk-bladder-cancer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/IDL2281web.jpg\",\"contentUrl\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/IDL2281web.jpg\",\"width\":1009,\"height\":640},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2018\\\/12\\\/11\\\/german-study-recommends-ubc-rapid-to-be-added-in-the-diagnostics-and-follow-up-of-high-risk-bladder-cancer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/idldiagnostics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"German study recommends UBC\u00ae Rapid to be added in the diagnostics and follow-up of high risk bladder cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#website\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/\",\"name\":\"IDL Diagnostics\",\"description\":\"Saving lives with diagnostics\",\"publisher\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/idldiagnostics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#organization\",\"name\":\"IDL Diagnostics\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/AroCell_logo.png\",\"contentUrl\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/AroCell_logo.png\",\"width\":1713,\"height\":570,\"caption\":\"IDL Diagnostics\"},\"image\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/arocell\",\"https:\\\/\\\/linkedin.com\\\/company\\\/arocell\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#\\\/schema\\\/person\\\/69060a052e2a36c16244e75262d43000\",\"name\":\"marie\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9710362952388fab63e5da805aba53ffa28210c7bbb0be5447148f193ce03ad4?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9710362952388fab63e5da805aba53ffa28210c7bbb0be5447148f193ce03ad4?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9710362952388fab63e5da805aba53ffa28210c7bbb0be5447148f193ce03ad4?s=96&d=mm&r=g\",\"caption\":\"marie\"},\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/se\\\/author\\\/marie\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"German study recommends UBC\u00ae Rapid to be added in the diagnostics and follow-up of high risk bladder cancer - IDL Diagnostics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/idldiagnostics.com\/se\/2018\/12\/11\/german-study-recommends-ubc-rapid-to-be-added-in-the-diagnostics-and-follow-up-of-high-risk-bladder-cancer\/","og_locale":"sv_SE","og_type":"article","og_title":"German study recommends UBC\u00ae Rapid to be added in the diagnostics and follow-up of high risk bladder cancer - IDL Diagnostics","og_description":"International Journal of Molecular Sciences has published a study on UBC\u00ae Rapid. In total 530 urine samples was included in the multicenterstudy. The author of the study concluded that elevated values of UBC\u00ae&nbsp;Rapid&nbsp;Test in urine are higher in patients with non-muscle invasive high-grade bladder cancer in comparison to low-grade tumors and the healthy control group. [&hellip;]","og_url":"https:\/\/idldiagnostics.com\/se\/2018\/12\/11\/german-study-recommends-ubc-rapid-to-be-added-in-the-diagnostics-and-follow-up-of-high-risk-bladder-cancer\/","og_site_name":"IDL Diagnostics","article_publisher":"https:\/\/www.facebook.com\/arocell","article_published_time":"2018-12-10T23:00:00+00:00","article_modified_time":"2021-05-26T08:09:39+00:00","og_image":[{"width":1009,"height":640,"url":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/IDL2281web.jpg","type":"image\/jpeg"}],"author":"marie","twitter_card":"summary_large_image","twitter_misc":{"Skriven av":"marie","Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/idldiagnostics.com\/2018\/12\/11\/german-study-recommends-ubc-rapid-to-be-added-in-the-diagnostics-and-follow-up-of-high-risk-bladder-cancer\/#article","isPartOf":{"@id":"https:\/\/idldiagnostics.com\/2018\/12\/11\/german-study-recommends-ubc-rapid-to-be-added-in-the-diagnostics-and-follow-up-of-high-risk-bladder-cancer\/"},"author":{"name":"marie","@id":"https:\/\/idldiagnostics.com\/#\/schema\/person\/69060a052e2a36c16244e75262d43000"},"headline":"German study recommends UBC\u00ae Rapid to be added in the diagnostics and follow-up of high risk bladder cancer","datePublished":"2018-12-10T23:00:00+00:00","dateModified":"2021-05-26T08:09:39+00:00","mainEntityOfPage":{"@id":"https:\/\/idldiagnostics.com\/2018\/12\/11\/german-study-recommends-ubc-rapid-to-be-added-in-the-diagnostics-and-follow-up-of-high-risk-bladder-cancer\/"},"wordCount":197,"commentCount":0,"publisher":{"@id":"https:\/\/idldiagnostics.com\/#organization"},"image":{"@id":"https:\/\/idldiagnostics.com\/2018\/12\/11\/german-study-recommends-ubc-rapid-to-be-added-in-the-diagnostics-and-follow-up-of-high-risk-bladder-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/IDL2281web.jpg","articleSection":["Bladder cancer"],"inLanguage":"sv-SE","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/idldiagnostics.com\/2018\/12\/11\/german-study-recommends-ubc-rapid-to-be-added-in-the-diagnostics-and-follow-up-of-high-risk-bladder-cancer\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/idldiagnostics.com\/2018\/12\/11\/german-study-recommends-ubc-rapid-to-be-added-in-the-diagnostics-and-follow-up-of-high-risk-bladder-cancer\/","url":"https:\/\/idldiagnostics.com\/2018\/12\/11\/german-study-recommends-ubc-rapid-to-be-added-in-the-diagnostics-and-follow-up-of-high-risk-bladder-cancer\/","name":"German study recommends UBC\u00ae Rapid to be added in the diagnostics and follow-up of high risk bladder cancer - IDL Diagnostics","isPartOf":{"@id":"https:\/\/idldiagnostics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/idldiagnostics.com\/2018\/12\/11\/german-study-recommends-ubc-rapid-to-be-added-in-the-diagnostics-and-follow-up-of-high-risk-bladder-cancer\/#primaryimage"},"image":{"@id":"https:\/\/idldiagnostics.com\/2018\/12\/11\/german-study-recommends-ubc-rapid-to-be-added-in-the-diagnostics-and-follow-up-of-high-risk-bladder-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/IDL2281web.jpg","datePublished":"2018-12-10T23:00:00+00:00","dateModified":"2021-05-26T08:09:39+00:00","breadcrumb":{"@id":"https:\/\/idldiagnostics.com\/2018\/12\/11\/german-study-recommends-ubc-rapid-to-be-added-in-the-diagnostics-and-follow-up-of-high-risk-bladder-cancer\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/idldiagnostics.com\/2018\/12\/11\/german-study-recommends-ubc-rapid-to-be-added-in-the-diagnostics-and-follow-up-of-high-risk-bladder-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/idldiagnostics.com\/2018\/12\/11\/german-study-recommends-ubc-rapid-to-be-added-in-the-diagnostics-and-follow-up-of-high-risk-bladder-cancer\/#primaryimage","url":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/IDL2281web.jpg","contentUrl":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/IDL2281web.jpg","width":1009,"height":640},{"@type":"BreadcrumbList","@id":"https:\/\/idldiagnostics.com\/2018\/12\/11\/german-study-recommends-ubc-rapid-to-be-added-in-the-diagnostics-and-follow-up-of-high-risk-bladder-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/idldiagnostics.com\/"},{"@type":"ListItem","position":2,"name":"German study recommends UBC\u00ae Rapid to be added in the diagnostics and follow-up of high risk bladder cancer"}]},{"@type":"WebSite","@id":"https:\/\/idldiagnostics.com\/#website","url":"https:\/\/idldiagnostics.com\/","name":"IDL Diagnostik","description":"R\u00e4dda liv med diagnostik","publisher":{"@id":"https:\/\/idldiagnostics.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/idldiagnostics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/idldiagnostics.com\/#organization","name":"IDL Diagnostik","url":"https:\/\/idldiagnostics.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/idldiagnostics.com\/#\/schema\/logo\/image\/","url":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/AroCell_logo.png","contentUrl":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/AroCell_logo.png","width":1713,"height":570,"caption":"IDL Diagnostics"},"image":{"@id":"https:\/\/idldiagnostics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/arocell","https:\/\/linkedin.com\/company\/arocell"]},{"@type":"Person","@id":"https:\/\/idldiagnostics.com\/#\/schema\/person\/69060a052e2a36c16244e75262d43000","name":"marie","image":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/secure.gravatar.com\/avatar\/9710362952388fab63e5da805aba53ffa28210c7bbb0be5447148f193ce03ad4?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9710362952388fab63e5da805aba53ffa28210c7bbb0be5447148f193ce03ad4?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9710362952388fab63e5da805aba53ffa28210c7bbb0be5447148f193ce03ad4?s=96&d=mm&r=g","caption":"marie"},"url":"https:\/\/idldiagnostics.com\/se\/author\/marie\/"}]}},"_links":{"self":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/posts\/1388","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/comments?post=1388"}],"version-history":[{"count":2,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/posts\/1388\/revisions"}],"predecessor-version":[{"id":2710,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/posts\/1388\/revisions\/2710"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/media\/2510"}],"wp:attachment":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/media?parent=1388"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/categories?post=1388"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/tags?post=1388"},{"taxonomy":"dipi_cpt_category","embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/dipi_cpt_category?post=1388"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}